Literature DB >> 12433858

Neural responses during Valsalva maneuvers in obstructive sleep apnea syndrome.

Luke A Henderson1, Mary A Woo, Paul M Macey, Katherine E Macey, Robert C Frysinger, Jeffry R Alger, Frisca Yan-Go, Ronald M Harper.   

Abstract

The repetitive upper airway muscle atonic episodes and cardiovascular sequelae of obstructive sleep apnea (OSA) suggest dysfunction of specific neural sites that integrate afferent airway signals with autonomic and somatic outflow. We determined neural responses to the Valsalva maneuver by using functional magnetic resonance imaging. Images were collected during a baseline and three Valsalva maneuvers in 8 drug-free OSA patients and 15 controls. Multiple cortical, midbrain, pontine, and medullary regions in both groups showed intensity changes correlated to airway pressure. In OSA subjects, the left inferior parietal cortex, superior temporal gyrus, posterior insular cortex, cerebellar cortex, fastigial nucleus, and hippocampus showed attenuated signal changes compared with controls. Enhanced responses emerged in the left lateral precentral gyrus, left anterior cingulate, and superior frontal cortex of OSA patients. The anterior cingulate, cerebellar cortex, and posterior insula exhibited altered response timing patterns between control and OSA subjects. The response patterns in OSA subjects suggest deficits in particular neural pathways that normally mediate the Valsalva maneuver and compensatory actions in other structures.

Entities:  

Mesh:

Year:  2002        PMID: 12433858     DOI: 10.1152/japplphysiol.00702.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  50 in total

1.  Is brain injury in obstructive sleep apnea reversible?

Authors:  Paul M Macey
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

2.  Interaction between Obstructive Sleep Apnea and Shortened Telomere Length on Brain White Matter Abnormality.

Authors:  Kyung-Mee Choi; Robert J Thomas; Dai Wui Yoon; Seung Ku Lee; Inkyung Baik; Chol Shin
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

3.  Cortical regions associated with autonomic cardiovascular regulation during lower body negative pressure in humans.

Authors:  Derek S Kimmerly; Deborah D O'Leary; Ravi S Menon; Joseph S Gati; J Kevin Shoemaker
Journal:  J Physiol       Date:  2005-09-08       Impact factor: 5.182

4.  Resting cerebral blood flow alteration in severe obstructive sleep apnoea: an arterial spin labelling perfusion fMRI study.

Authors:  Si Nie; De-Chang Peng; Hong-Han Gong; Hai-Jun Li; Li-Ting Chen; Cheng-Long Ye
Journal:  Sleep Breath       Date:  2017-02-16       Impact factor: 2.816

Review 5.  Obstructive Sleep Apnoea and Hypertension: the Role of the Central Nervous System.

Authors:  Luke A Henderson; Vaughan G Macefield
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

Review 6.  Sudden unexpected death in epilepsy or voodoo heart: analysis of heart/brain connections.

Authors:  Narges Moghimi; Samden D Lhatoo
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 7.  New insights on the role of the insular cortex and habenula in OSA.

Authors:  Ming-Xian Li; Chao-Ying Yan; Shao Wang
Journal:  Sleep Breath       Date:  2015-05-10       Impact factor: 2.816

8.  Global and Regional Brain Non-Gaussian Diffusion Changes in Newly Diagnosed Patients with Obstructive Sleep Apnea.

Authors:  Sudhakar Tummala; Jose Palomares; Daniel W Kang; Bumhee Park; Mary A Woo; Ronald M Harper; Rajesh Kumar
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

9.  Neural alterations associated with anxiety symptoms in obstructive sleep apnea syndrome.

Authors:  Rajesh Kumar; Paul M Macey; Rebecca L Cross; Mary A Woo; Frisca L Yan-Go; Ronald M Harper
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

10.  Central nervous system changes in pediatric heart failure: a volumetric study.

Authors:  Jondavid Menteer; Paul M Macey; Mary A Woo; Ashok Panigrahy; Ronald M Harper
Journal:  Pediatr Cardiol       Date:  2010-06-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.